SCHEMBL18668145

SCHEMBL18668145

CC(C)(O)c1ncccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.39
PDE2A O00408 1/20 0.36
PDE10A Q9Y233 1/20 0.36
LMNA P02545 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HSP90AA1 P07900 2/20 0.36
MAPT P10636 2/20 0.36
BRD4 O60885 1/20 0.36
METAP2 P50579 1/20 0.36
METAP1 P53582 1/20 0.36
TRPV1 Q8NER1 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
CYP3A4 P08684 2/20 0.35
HTT P42858 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
ALOX15B O15296 1/20 0.35
NR1I2 O75469 1/20 0.35
TP53 P04637 1/20 0.35
HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179292 0.83 TRPV1 (0.37) LMNAKDM4EHSP90AA1MAPTBRD4
SCHEMBL29724855 0.79 DPP4 (0.36) LMNAKDM4ETRPV1SMN1; SMN2HTT
SCHEMBL1334085 0.79 LMNA (0.36) LMNAKDM4EHSP90AA1MAPTBRD4
SCHEMBL369947 0.79 TRPV1 (0.35) TRPV1TDP1NFE2L2GRM4
SCHEMBL3257764 0.78 TDP1 (0.39) LMNAKDM4EHSP90AA1MAPTBRD4
SCHEMBL30592740 0.78 TDP1 (0.39) LMNAKDM4EHSP90AA1MAPTBRD4
SCHEMBL365596 0.77 SMN1; SMN2 (0.42) LMNAKDM4ETRPV1SMN1; SMN2CYP3A4
SCHEMBL30816293 0.77 NOS3 (0.50) LMNAKDM4EHSP90AA1MAPTSMN1; SMN2
SCHEMBL5038676 0.77 ALDH1A1 (0.44) KDM4EMETAP2METAP1SMN1; SMN2CYP3A4
SCHEMBL130124 0.77 NOS3 (0.50) LMNAKDM4EHSP90AA1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017051319-A1 ARYL AND HETEROARYL ETHER COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-03-30 WO disclosed